Stimuli-responsive prodrug-based cancer nanomedicine

Yang, 2017, Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses, Nat Commun, 8, 902, 10.1038/s41467-017-01050-0

Bai, 2018, Reduction stimuli-responsive unimolecular polymeric prodrug based on amphiphilic dextran-framework for antitumor drug delivery, Carbohydr Polym, 182, 235, 10.1016/j.carbpol.2017.11.028

Ouyang, 2018, Biomimetic nanothylakoids for efficient imaging-guided photodynamic therapy for cancer, Chem Commun, 54, 3468, 10.1039/C8CC00674A

Ouyang, 2018, Two dimensional semiconductors for ultrasound-mediated cancer therapy: the case of black phosphorus nanosheets, Chem Commun, 54, 2874, 10.1039/C8CC00392K

Zhang, 2018, Erythrocyte membrane cloaked metal–organic framework nanoparticle as biomimetic nanoreactor for starvation-activated colon cancer therapy, ACS Nano, 10.1021/acsnano.8b05200

Tao, 2018, Two-dimensional antimonene-based photonic nanomedicine for cancer theranostics, Adv Mater, 30

Strozyk, 2017, Biocompatible, multiresponsive nanogel composites for codelivery of antiangiogenic and chemotherapeutic agents, Chem Mater, 29, 2303, 10.1021/acs.chemmater.6b05471

Lu, 2016, Bioresponsive materials, Nat Rev Mater, 2, 16075, 10.1038/natrevmats.2016.75

Luo, 2014, Prodrug-based nanoparticulate drug delivery strategies for can- cer therapy, Trends Pharmacol Sci, 35, 556, 10.1016/j.tips.2014.09.008

Xu, 2017, ROS-responsive polyprodrug nanoparticles for triggered drug delivery and effective cancer therapy, Adv Mater, 29, 10.1002/adma.201700141

Ling, 2019, Glutathione-Responsive Prodrug Nanoparticles for Effective Drug Delivery and Cancer Therapy, ACS Nano, 13, 357, 10.1021/acsnano.8b06400

Zhang, 2016, Acid-Responsive Polymeric Doxorubicin Prodrug Nano-particles Encapsulating a Near-Infrared Dye for Combined Photothermal-Chemotherapy, Chem Mater, 28, 7039, 10.1021/acs.chemmater.6b02896

Guan, 2019, Enzyme-responsive sulfatocyclodextrin/prodrug supramolecular assembly for controlled release of anti-cancer drug chlorambucil, Chem Commun, 55, 953, 10.1039/C8CC09047E

Cui, 2019, A semiconducting polymer nano-prodrug for hypoxia-activated photodynamic cancer therapy, Angew Chem Int Ed, 58, 5920, 10.1002/anie.201814730

Sun, 2018, Disulfide bond-driven oxidation- and reduction-responsive prodrug nanoassemblies for cancer therapy, Nano Lett, 18, 3643, 10.1021/acs.nanolett.8b00737

Dai, 2013, In Vivo multimodality imaging and cancer therapy by near-infrared light-triggered trans-platinum pro-drug-conjugated upconverison nanoparticles, J Am Chem Soc, 135, 18920, 10.1021/ja410028q

McDaniel, 2013, Self-assembly of thermally responsive nanoparticles of a genetically encoded peptide polymer by drug conjugation, Angew Chem Int Ed, 52, 1683, 10.1002/anie.201200899

Arias, 2011, Squalene based nanocomposites: a new platform for the design of multifunctional pharmaceutical theragnostics, ACS Nano, 5, 1513, 10.1021/nn1034197

Wang, 2016, Antitumor gemcitabine conjugated micelles from amphiphilic comb-like random copolymers, Colloids Surf B, 146, 707, 10.1016/j.colsurfb.2016.07.027

Li, 2017, Polymer prodrug-based nanoreactors activated by tumor acidity for orchestrated oxidation/chemotherapy, Nano Lett, 17, 6983, 10.1021/acs.nanolett.7b03531

Duan, 2018, PEGylated multistimuli-responsive dendritic prodrug-based nanoscale system for enhanced anticancer activity, ACS Appl Mater Interfaces, 10, 35770, 10.1021/acsami.8b12232

Cheetham, 2017, Self-assembling prodrugs, Chem Soc Rev, 46, 6638, 10.1039/C7CS00521K

Teng, 2017, Polyamino acid-based gemcitabine nanocarriers for targeted intracellular drug delivery, Polym Chem, 8, 2490, 10.1039/C7PY00443E

Bai, 2018, Photo- and pH- dual-responsive β-cyclodextrin-based supramolecular prodrug complex self-assemblies for programmed drug delivery, Chem–Asian J, 13, 3903, 10.1002/asia.201801366

Wang, 2015, Pillar[5]arene based supramolecular prodrug micelles with pH induced aggregate behavior for intracellular drug delivery, Chem Commun, 51, 2999, 10.1039/C4CC09274K

Peng, 2016, Self-delivery of a peptide-based prodrug for tumor-targeting therapy, Nano Res, 9, 663, 10.1007/s12274-015-0945-1

Caron, 2013, Improving the antitumor activity of squalenoyl-paclitaxel conjugate nanoassemblies by manipulating the linker between paclitaxel and squalene, Adv Healthc Mater, 2, 172, 10.1002/adhm.201200099

Yue, 2018, Coordination-driven self-assembly of a Pt(IV) prodrug-conjugated supramolecular hexagon, Chem Commun, 54, 731, 10.1039/C7CC07622C

Fang, 2018, Reprogramming axial ligands facilitates the self-assembly of a platinum(IV) prodrug: overcoming drug resistance and safer in vivo delivery of cisplatin, Chem Commun, 54, 9167, 10.1039/C8CC03763A

Yang, 2018, Light-activatable dual-source ROS-responsive prodrug nanoplatform for synergistic chemo-photodynamic therapy, Biomater Sci, 6, 2965, 10.1039/C8BM00899J

Lv, 2018, Nanoplatform assembled from a CD44-targeted prodrug and smart liposomes for dual targeting of tumor microenvironment and cancer Cells, ACS Nano, 12, 1519, 10.1021/acsnano.7b08051

Hu, 2019, Bortezomib dendrimer prodrug‐based nanoparticle system, Adv Funct Mater, 29, 10.1002/adfm.201807941

Chen, 2016, Endogenous stimuli-responsive nanocarriers for drug delivery, Chem Lett, 45, 242, 10.1246/cl.151176

Huang, 2016, A lysosome-targeted fluorescent sensor for the detection of glutathione in cells with an extremely fast response, Chem Commun, 52, 11579, 10.1039/C6CC06750F

Lee, 2015, Disulfide-based multifunctional conjugates for targeted theranostic drug delivery, Acc Chem Res, 48, 2935, 10.1021/acs.accounts.5b00406

Zhang, 2018, Polymeric nanoparticles with a glutathione‐sensitive heterodimeric multifunctional prodrug for in vivo drug monitoring and synergistic cancer therapy, Angew Chem Int Ed, 57, 7066, 10.1002/anie.201801984

Peng, 2012, ROS-activated anticancer prodrugs: a new strategy for tumor- specific damage, Ther Deliv, 3, 823, 10.4155/tde.12.61

Dela Rica, 2012, Enzyme-responsive nanoparticles for drug release and diagnostics, Adv Drug Deliv Rev, 64, 967, 10.1016/j.addr.2012.01.002

Hu, 2014, Enzyme-responsive nanomaterials for controlled drug delivery, Nanoscale, 6, 12273, 10.1039/C4NR04249B

Li, 2017, Enzyme-Sensitive and Amphiphilic PEGylated Dendrimer-Paclitaxel Prodrug-Based Nanoparticles for Enhanced Stability and Anticancer Efficacy, ACS Appl Mater Interfaces, 9, 6865, 10.1021/acsami.6b15505

Thambi, 2016, Hypoxia-responsive nanocarriers for cancer imaging and therapy: recent approaches and future perspectives, Chem Commun, 10.1039/C6CC02972H

Cui, 2019, A semiconducting polymer nano‐prodrug for hypoxia‐activated photodynamic cancer therapy, Angew Chem Int Ed, 58, 5920, 10.1002/anie.201814730

Hua, 2018, Hypoxia-responsive lipid-poly-(hypoxic radiosensitized polyprodrug) nanoparticles for glioma chemo-and radiotherapy, Theranostics, 8, 5088, 10.7150/thno.26225

Sun, 2018, Disulfide bond-driven oxidation-and reduction-responsive prodrug nanoassemblies for cancer therapy, Nano Lett, 18, 3643, 10.1021/acs.nanolett.8b00737

Mura, 2013, Stimuli-responsive nanocarriers for drug delivery, Nat Mater, 12, 991, 10.1038/nmat3776

Schroeder, 2012, Remotely activated protein-producing nanoparticles, Nano Lett, 12, 2685, 10.1021/nl2036047

Yang, 2016, Near-infrared-light responsive nanoscale drug delivery systems for cancer treatment, Coord Chem Rev, 320, 100, 10.1016/j.ccr.2016.04.004

Jia, 2018, Photoswitchable molecules in long-wavelength light-responsive drug delivery: from molecular design to applications, Chem Mater, 30, 2873, 10.1021/acs.chemmater.8b00357

Azagarsamy, 2012, Photocontrol-led nanoparticles for on-demand release of proteins, Biomacromolecules, 13, 2219, 10.1021/bm300646q

Tong, 2012, Drug-initiated, controlled ring-opening polymerization for the synthesis of polymer–drug conjugates, Macromolecules, 45, 2225, 10.1021/ma202581d

Cosa, 2009, How drug photodegradation studies led to the promise of new therapies and some fundamental carbanion reaction dynamics along the way, Acc Chem Res, 42, 599, 10.1021/ar8001969

Hu, 2013, Photo-triggered release of caged camptothecin prodrugs from dually responsive shell cross-linked micelles, Macromolecules, 46, 6243, 10.1021/ma400691j

Zhou, 2016, Simultaneously Photo‐Cleavable and Activatable Prodrug‐Backboned Block Copolymer Micelles for Precise Anticancer Drug Delivery, Adv Healthc Mater, 5, 2493, 10.1002/adhm.201600470

Lee, 2016, Liposomal texaphyrin theranostics for metastatic liver cancer, J Am Chem Soc, 138, 16380, 10.1021/jacs.6b09713

Rwei, 2015, Photoresponsive nanoparticles for drug delivery, Nano Today, 10, 451, 10.1016/j.nantod.2015.06.004

Yuan, 2014, NIR photoregulated chemo-and photo-dynamic cancer therapy based on conjugated polyelectrolyte–drug conjugate encapsulated upconversion nanoparticles, Nanoscale, 6, 11259, 10.1039/C4NR03302G

Fleige, 2012, Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications, Adv Drug Deliv Rev, 64, 866, 10.1016/j.addr.2012.01.020

Karimi, 2016, Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems, Chem Soc Rev, 45, 1457, 10.1039/C5CS00798D

Deka, 2011, Magnetic nanobeads decorated by thermoresponsive PNIPAM shell as medical platforms for the efficient delivery of doxorubicin to tumour cells, Nanoscale, 3, 619, 10.1039/C0NR00570C

Topp, 1997, Thermosensitive micelle-forming block copolymers of poly (ethylene glycol) and poly (N-isopropylacrylamide), Macromolecules, 30, 8518, 10.1021/ma9710803

Peng, 2016, A facile approach for thermal and reduction dual-responsive prodrug nanogels for intracellular doxorubicin delivery, J Mater Chem B, 4, 7572, 10.1039/C6TB01285J

Chen, 2015, Targeted tumor theranostics using folate- conjugated and camptothecin-loaded acoustic nanodroplets in a mouse xenograft model, Biomaterials, 53, 699, 10.1016/j.biomaterials.2015.02.122

Gao, 2019, Ultrasound triggered phase-change nanodroplets for doxorubic-in prodrug delivery and ultrasound diagnosis: an in vitro study, Colloids Surf B, 174, 416, 10.1016/j.colsurfb.2018.11.046

Luo, 2017, Dual-targeted and pH-sensitive doxorubicin prodrug-microbubble complex with ultrasound for tumor treatment, Theranostics, 7, 452, 10.7150/thno.16677

Kainz, 2014, Polymer-and dendrimer-coated magnetic nanoparticles as versa-tile supports for catalysts, scavengers, and reagents, Acc Chem Res, 47, 667, 10.1021/ar400236y

Ulbrich, 2016, Targeted drug delivery with polymers and magnetic nanoparticles: covalent and noncovalent approaches, release control, and clinical studies, Chem Rev, 116, 5338, 10.1021/acs.chemrev.5b00589

Wang, 2012, Magnetic-Fe/Fe3O4-nanoparticle-bound SN38 as carboxylesterase-cleavable prodrug for the delivery to tumors within monocytes/macrophages, Beilstein J Nanotech, 3, 444, 10.3762/bjnano.3.51

Yang, 2011, Self-protecting core-shell magnetic nanoparticles for targeted, traceable, long half-life delivery of BCNU to gliomas, Biomaterials, 32, 6523, 10.1016/j.biomaterials.2011.05.047

Norman, 2018, Electrodrugs: an electrochemical prodrug activation strategy, Chem Commun, 54, 9242, 10.1039/C8CC04151B

Putnam, 1995, Polymer conjugates with anticancer activity, Biopolymers Ii: Springer, 55, 10.1007/3540587888_14

Yang, 2016, Improvement of the in vitro safety profile and cytoprotective efficacy of amifostine against chemotherapy by PEGylation strategy, Biochem Pharacol, 108, 11, 10.1016/j.bcp.2016.02.014

Duncan, 2001, Polymer–drug conjugates, PDEPT PELT: basic Princ Des Transf Lab Clin, 74, 135

Khandare, 2006, Polymer–drug conjugates: progress in polymeric prodrugs, Prog Polym Sci, 31, 359, 10.1016/j.progpolymsci.2005.09.004

Sievers, 2013, Antibody-drug conjugates in cancer therapy, Annu Rev Med, 64, 15, 10.1146/annurev-med-050311-201823

Alley, 2010, Antibody–drug conjugates: targeted drug delivery for cancer, Curr Opin Chem Biol, 14, 529, 10.1016/j.cbpa.2010.06.170

Verma, 2012, Trastuzumab emtansine for HER2-positive advanced breast cancer, New Engl J Med, 367, 1783, 10.1056/NEJMoa1209124

Kantarjian, 2012, Inotuzumab ozogamicin, an anti-CD22–calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study, Lancet Neurol, 13, 403

Deeks, 2019, Polatuzumab vedotin: first global approval, Drugs, 79, 1467, 10.1007/s40265-019-01175-0

Rosenberg, 2019, Pivotal trial of enfortumab vedotin in urothelial carcinoma after platinum and anti-programmed death 1/programmed death ligand 1 therapy, J Clin Oncol, 37, 2592, 10.1200/JCO.19.01140

Coats, 2019, Antibody–drug conjugates: future directions in clinical and translational strategies to improve the therapeutic index, Clin Cancer Res, 25, 5441, 10.1158/1078-0432.CCR-19-0272

LoPachin, 2005, 21

Han, 2014, Absorption, distribution, metabolism, and excretion considerations for the development of antibody-drug conjugates, Drug Metab Dispos, 42, 1914, 10.1124/dmd.114.058586

Cheng, 2009, Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial, Lancet Neurol, 10, 25

Hou, 2018, Methotrexate-based amphiphilic prodrug nanoaggregates for co-administration of multiple therapeutics and synergistic cancer therapy, Acta Biomater, 77, 228, 10.1016/j.actbio.2018.07.014

Lindner, 2008, Dual role of hexadecylphosphocholine (miltefosine) in thermosensitive liposomes: active ingredient and mediator of drug release, J Control Release, 125, 112, 10.1016/j.jconrel.2007.10.009

Ji, 2019, Enhanced Natural Killer Cell Immunotherapy by Rationally Assembling Fc Fragments of Antibodies onto Tumor Membranes, Adv Mater, 31, 10.1002/adma.201804395

Sharma, 2018, Overcoming drug resistance by targeting cancer bioenergetics with an activatable prodrug, Chem, 4, 2370, 10.1016/j.chempr.2018.08.002